Peripheral Artery Disease Market by Type - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403082
  • Report
  • Region: Global
  • 150 pages
  • Allied Analytics LLP
1 of 3
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.

The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a CAGR of 6.8% during the study period. The growth in geriatric population coupled with increase in incidence of peripheral artery disease are the major factors that drive the growth of the peripheral artery disease market. In addition, introduction of advanced interventional products such as drug coated balloons also boost the market growth. However, restenosis (reoccurrence of the disease post treatment) majorly restraints the market growth.

The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 2016–2023 that helps identify the upcoming market opportunities.
Recent industry trends and developments and the future opportunities are also covered.
Extensive knowledge about the key market players and their strategies is provided.
Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

KEY MARKET SEGMENTS

By Type

Peripheral Angioplasty Balloons
Old/Normal Balloons
Cutting and Scoring Balloons
Drug-Coated Balloons
Peripheral Stents
Self-expandable
Balloon-expandable
Covered
Drug-eluting Stents
Peripheral Catheters
Angiography Catheters
Guiding Catheters
Inferior Vena Cava (IVC) Filters
Permanent Filters
Retrievable Filters
Plaque Modification Devices
Thrombectomy Devices
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
Atherectomy Devices
Hemodynamic Flow Alteration Devices
Embolic Protection Devices
Chronic Total Occlusion Devices
Peripheral Accessories
Vascular Closure Devices
Introducer Sheaths
Guidewires
Balloon Inflation Devices

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key market players

The key players operating in this market include

Abbott Laboratories
Boston Scientific Corporation
Cook Medical
Cardinal Health, Inc.
C. R. Bard, Inc.
Medtronic plc
Terumo Corporation
The Spectranetics Corporation
AngioDynamics, Inc.
BIOTRONIK
B. Braun Melsungen AG
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing geriatric population and increasing prevalence of chronic diseases
3.3.1.2. Introduction of advanced interventional products
3.3.1.3. Improvement of healthcare infrastructure in developing countries
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Restenosis
3.3.2.2. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Market opportunities in developing countries

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PERIPHERAL ANGIOPLASTY BALLOONS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Old/Normal Balloons

4.2.4.1. Market size and forecast

4.2.5. Cutting and Scoring Balloons

4.2.5.1. Market size and forecast

4.2.6. Drug-Coated Balloons

4.2.6.1. Market size and forecast

4.3. PERIPHERAL STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Self-expandable

4.3.4.1. Market size and forecast

4.3.5. Balloon-expandable

4.3.5.1. Market size and forecast

4.3.6. Covered stents

4.3.6.1. Market size and forecast

4.3.7. Drug-eluting Stents

4.3.7.1. Market size and forecast

4.4. ANGIOPLASTY CATHETERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Angiography Catheters

4.4.4.1. Market size and forecast

4.4.5. Guiding Catheters

4.4.5.1. Market size and forecast

4.5. INFERIOR VENA CAVA (IVC) FILTERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Permanent Filters

4.5.4.1. Market size and forecast

4.5.5. Retrievable Filters

4.5.5.1. Market size and forecast

4.6. PLAQUE MODIFICATION DEVICES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Thrombectomy Devices

4.6.4.1. Market size and forecast
4.6.4.2. Mechanical Thrombectomy Devices
4.6.4.3. Market size and forecast
4.6.4.4. Aspiration Thrombectomy Devices
4.6.4.5. Market size and forecast
4.6.4.6. Rheolytic Thrombectomy Devices
4.6.4.7. Market size and forecast

4.6.5. Atherectomy Devices

4.6.5.1. Market size and forecast

4.7. HEMODYNAMIC FLOW ALTERATION DEVICES

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Embolic Protection Devices

4.7.4.1. Market size and forecast

4.7.5. Chronic Total Occlusion Devices

4.7.5.1. Market size and forecast

4.8. PERIPHERAL ACCESSORIES

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.8.4. Peripheral vascular Closure Devices

4.8.4.1. Market size and forecast

4.8.5. Introducer Sheaths

4.8.5.1. Market size and forecast

4.8.6. Guidewires

4.8.6.1. Market size and forecast

4.8.7. Balloon Inflation Devices

4.8.7.1. Market size and forecast

CHAPTER 5 PERIPHERAL ARTERY DISEASE MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. BOSTON SCIENTIFIC CORPORATION

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. COOK

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. CARDINAL HEALTH, INC.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. C. R. BARD, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. TERUMO CORPORATION

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. SPECTRANETICS

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. ANGIODYNAMICS

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. BIOTRONIK

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

6.11. B. BRAUN MELSUNGEN AG

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll